[Glutamine, glutamate and citrulline concentration in blood plasma in patients in critical condition (pilot study

Insights

In critical condition patients, altered glutamate levels correlate with gastrointestinal electrical activity and survival. Hypofunction of the glutamatergic system is linked to worse outcomes and impaired gut motility.

Area of Science:

  • Critical care medicine
  • Gastroenterology
  • Biochemistry

Context:

  • Patients in critical condition (CC) often experience gastrointestinal dysfunction.
  • The role of the glutamatergic system in CC-related gut motility disorders is not fully understood.

Purpose:

  • To evaluate plasma levels of glutamine, glutamate, and citrulline in relation to small intestine electrical activity in critically ill patients.
  • To compare these parameters with patient outcomes, including 28-day survival.

Summary:

  • Plasma levels of glutamine, glutamate (Gl-p), and citrulline (Cit-p) were measured in 27 critically ill patients.
  • Patients were categorized into glutamatergic system hypofunction (HCS) or normofunction (NGS) based on Gl-p and Cit-p levels.
  • HCS was associated with increased proximal small intestine electrical activity (EA) and reduced 28-day survival.

Impact:

  • Findings suggest the glutamatergic system's involvement in the pathogenesis of gastrointestinal motor activity disorders in CC.
  • Altered glutamate metabolism and small intestine EA may serve as potential diagnostic markers.
  • This research supports the rationale for correcting glutamatergic hypofunction in critically ill patients.
Abstract